U.S. flag

An official website of the United States government

NM_004531.5(MOCS2):c.65dup (p.Leu23fs) AND Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 1, 2003
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000006485.4

Allele description [Variation Report for NM_004531.5(MOCS2):c.65dup (p.Leu23fs)]

NM_004531.5(MOCS2):c.65dup (p.Leu23fs)

Gene:
MOCS2:molybdenum cofactor synthesis 2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
5q11.2
Genomic location:
Preferred name:
NM_004531.5(MOCS2):c.65dup (p.Leu23fs)
HGVS:
  • NC_000005.10:g.53107116dup
  • NG_008435.2:g.7659dup
  • NM_004531.5:c.65dupMANE SELECT
  • NM_176806.2:c.252dup
  • NM_176806.4:c.252dup
  • NP_004522.1:p.Leu23fs
  • NP_789776.1:p.Ile85fs
  • NC_000005.9:g.52402939_52402940insG
  • NC_000005.9:g.52402946dup
  • NM_176806.3:c.252dup
Protein change:
I85fs
Links:
OMIM: 603708.0004; dbSNP: rs398122799
NCBI 1000 Genomes Browser:
rs398122799
Molecular consequence:
  • NM_004531.5:c.65dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_176806.4:c.252dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B
Synonyms:
Molybdenum cofactor deficiency, complementation group B; Molybdenum cofactor deficiency B
Identifiers:
MONDO: MONDO:0009644; MedGen: C1854989; Orphanet: 833; OMIM: 252160

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000026668OMIM
no assertion criteria provided
Pathogenic
(Jun 1, 2003)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B.

Reiss J, Dorche C, Stallmeyer B, Mendel RR, Cohen N, Zabot MT.

Am J Hum Genet. 1999 Mar;64(3):706-11.

PubMed [citation]
PMID:
10053004
PMCID:
PMC1377787

Human molybdopterin synthase gene: identification of a bicistronic transcript with overlapping reading frames.

Stallmeyer B, Drugeon G, Reiss J, Haenni AL, Mendel RR.

Am J Hum Genet. 1999 Mar;64(3):698-705.

PubMed [citation]
PMID:
10053003
PMCID:
PMC1377786
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000026668.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

In a Portuguese patient with molybdenum cofactor deficiency (MOCODB; 252160), Reiss et al. (1999) found homozygosity for insertion of a C after nucleotide 252 in exon 3.

The 2 MOCS2 ORFs appear to be translated into 2 different proteins, MOCS2A and MOCS2B, from a single transcript with no alternative splicing involved (Stallmeyer et al., 1999). Reiss and Johnson (2003) stated that, consequently, the 252insC insertion mutation, which falls in the overlap region of MOCS2A and MOCS2B and was identified in a single patient, is the only mutation that affects both MOCS2 ORFs.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024